Expired Manager Statistical Programming jobs in Boise, ID
Loxo@Lilly
Boise, ID
$79,792-$148,877/year (est.)
Loxo@Lilly conducts discovery research, clinical development and regulatory affairs for oncology, with the goal of creating a pipeline of therapies that have the potential to make a meaningful difference for patients. Loxo@Lilly was created in December 2019, combining the Lilly Research...
Sumitomo Pharma
Boise, ID
$124K-$163K / yr.
Senior Manager, Statistical Programming Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. The company’s...
Boise, ID
$41,478-$151,276/year (est.)
Manager, Statistical Programming required to work for Labcorp Drug Development. You will be employed by Labcorp Drug Development working in our late phase (II-IV) full-service group with the opportunity to work across multiple therapeutic areas Home based anywhere in the US or Canada. You must have...
Boise, ID
$41,478-$151,276/year (est.)
BeiGene continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in...
Loxo@Lilly
Boise, ID
$41,478-$151,276/year (est.)
About Loxo@Lilly: Loxo@Lilly aims to create medicines that make life better for all those affected by cancer around the world. Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for...
Sumitomo Pharma
Boise, ID
$99K-$131K / yr.
Manager, Statistical Programming Sumitomo Pharma America (SMPA) is focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need spanning psychiatry & neurology, oncology, urology, women’s health, rare disease, and cell & gene therapies. The company’s diverse...